adverse outcomes – Page 7 – Communicable Diseases Research

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

혈액 악성 악성 종양이있는 성인 환자의 COVID-19 감염 : 유럽 혈액학 협회 조사 (Epicovideha)

Clinical Trial

Published on 2021-10-142022-08-13
Journal: Journal of Hematology & Oncology [Category] MERS, SARS, 임상, 진단,

SARS-CoV-2 and Atherosclerosis: Should COVID-19 Be Recognized as a New Predisposing Cardiovascular Risk Factor?

Commentary

Published on 2021-10-102022-10-30
Journal: Journal of Cardiovascular Development and Disease [Category] COVID-19,

Increased serum catalytic iron may mediate tissue injury and death in patients with COVID-19

증가 된 혈청 촉매 철분은 Covid-19 환자에서 조직 손상 및 사망을 매개 할 수 있습니다.

Article

Published on 2021-10-042022-09-10
Journal: Scientific Reports [Category] MERS, SARS, 바이오마커, 임상, 치료기술,

[키워드] 95% CI active form Adult patients adverse outcome adverse outcomes age age and gender Analysis association baseline levels Biomarkers catalytic Clinical diagnosis Composite COVID-19 cross-sectional death determine disease disease severity enrolled examined Factor ferritin ferritin level ferritin levels hepcidin in-hospital mortality Increased Infectious diseases iron iron chelation Iron metabolism joint kidney males mechanical ventilation median age metabolism Molecular biology Molecular medicine occurred outcome parameter Pathogenesis pathophysiologic pathophysiology pathway Patient patients patients hospitalized patients with COVID-19 Previous studies previous study Primary outcome Prognostic markers raising replacement therapy serum significantly therapy tissue injury Transferrin Ventilation was done
[DOI] 10.1038/s41598-021-99142-x PMC 바로가기 [Article Type] Article

Association of Inflammatory Biomarkers with Immunosuppression Management and Outcomes in Kidney Transplant Recipients with COVID-19

COVID-19를 가진 신장 이식 수혜자의 면역 억제 관리 및 결과와 염증성 바이오마커의 연관성

Article

Published on 2021-10-012022-09-11
Journal: Transplantation proceedings [Category] 바이오마커,

[키워드] 95% CI 95% confidence interval Acute kidney injury acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Admission Admissions adverse outcomes AKI association baseline Biomarker blood cell C-reactive protein calcineurin Chain Reaction change changes in Clinical management CNI Composite coronavirus coronavirus disease Coronavirus disease 2019 correlated COVID-19 creatinine death determine dialysis died dose EGFR estimated glomerular filtration rate Factor filtration rate glomerular filtration rate High-sensitivity C-reactive protein highest Hospitalized hs-CRP ICU ICU admission ICU admissions Immunosuppression increased risk Inflammatory biomarker inflammatory biomarkers inhibitor intensive care intensive care unit interquartile range investigated IQR kidney transplant recipient kidney transplant recipients manifestation median multivariable model Odds ratio outcome outcomes patients patients with AKI polymerase chain polymerase chain reaction positive recipient reduction remained required respiratory risk SARS-CoV-2 Transplant White blood cell white blood cell count with COVID-19
[DOI] 10.1016/j.transproceed.2021.08.002 PMC 바로가기 [Article Type] Article

Body composition predictors of outcome in patients with COVID-19

COVID-19 환자의 결과에 대한 체성분 예측 인자

Article

Published on 2021-10-012022-09-11
Journal: International journal of obesity (2005) [Category] 바이오마커,

[키워드] 95% CI abdominal muscle adipose Adipose tissue adjusted Admission adverse outcome adverse outcomes age Biomarker BMI Body body composition cardiometabolic clinical clinical information Comorbidities competing cross-sectional area CsA death Deceased distribution elevated fat hazard ratio Hospital admission ICU ICU admission increase in independent independent of information intensive care intensive care unit measure median median age median time multivariate muscle mass obesity outcome Patient patients hospitalized patients with COVID-19 predictor Prognostic factors reduced Retrospective study risk risk factor SAT Sex single hospital Standard deviation study group time of death tissue visceral were assessed with COVID-19
[DOI] 10.1038/s41366-021-00907-1 PMC 바로가기 [Article Type] Article

Accumulation of CD28 null Senescent T-Cells Is Associated with Poorer Outcomes in COVID19 Patients

CD28 널 노화 된 T- 세포의 축적은 COVID19 환자의 불량한 결과와 관련이 있습니다.

Review

Published on 2021-09-292022-08-31
Journal: Biomolecules [Category] 바이오마커, 유전자 메커니즘,

[키워드] accumulation acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adverse outcome adverse outcomes aging array Asymptomatic Cancer cause CD28 CD28^null T-cells Cell chronic obstructive chronic obstructive pulmonary disease chronic obstructive pulmonary disease (COPD) condition COPD coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID19 cytotoxicity death diabetes disease expansion hypertension immune decline individual Infection Infectious disease Inflammation inflammatory conditions morbidity and mortality mortality rates null cells obstructive pulmonary disease Patient populations potential mechanism potential mechanisms pulmonary disease respiratory Risk factors SARS-CoV-2 senescence senescent severe acute respiratory syndrome Coronavirus severity of COVID-19 Severity of infection Symptom T-cell T-cells Treatment underlying conditions
[DOI] 10.3390/biom11101425 PMC 바로가기 [Article Type] Review

Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19

임산부의 신규 비율 가용성 FMS- 유사 티로신 키나제 -1/안지오텐신 -II (SFLT-1/ang-II)는 Covid-19의 임계 질환과 관련이있다.

Brief Report

Published on 2021-09-232022-09-10
Journal: Viruses [Category] SARS, 바이오마커,

[키워드] ACE-2 adverse event adverse events adverse outcome adverse outcomes ANG-II Angiogenesis angiotensin angiotensin-II association binding cohort study component components contribute correlation COVID-19 death healthy hypoxia ICU admission illness intubation Invasion Logistic regression analysis marker Maternal death Migration novel Odds ratio outcome Pathogenesis pathogenesis of COVID-19 placental Pneumonia pregnancies pregnant women Primary outcome Probability Prospective prospective cohort study RAS Ratio receptor Renin renin-angiotensin system secondary Secondary outcomes Sepsis severe pneumonia sFlt-1 tyrosine was determined was used with COVID-19
[DOI] 10.3390/v13101906 PMC 바로가기 [Article Type] Brief Report

Prevalence, determinants, and outcomes of SARS‐COV‐2 infection among cancer patients. A population‐based study in northern Italy

Research Article

Published on 2021-09-222022-10-31
Journal: Cancer Medicine [Category] COVID-19, MERS,

[키워드] 95% confidence interval adjusted Admission adverse outcome adverse outcomes age calculated Cancer cancer diagnosis cancer patient Cancer patients Care CIs conducted death determinant determinants elevated evaluate Fatality rate hazard higher risk HRs ICU ICU admission in both groups individual individuals Infection intensive care investigated Italy Mortality much higher multivariable logistic regression outcome pandemic positive Prevalence PROTECT reduced reducing reported Result retrieved risk risk factor Risk factors SARS‐CoV‐2 SARS‐CoV‐2 infection SARS‐CoV‐2 Sex significant difference tested uninfected
[DOI] 10.1002/cam4.4271 PMC 바로가기 [Article Type] Research Article

Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients

Article

Published on 2021-09-172022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

[키워드] adjusted Admission adverse outcomes age albumin ALT Analysis analyzed association AST blood test center chronic liver disease clinical clinical outcomes Clinical severity Comorbidity Coronavirus disease 2019 COVID-19 COVID-19 severity death defined derangement Elevation evaluate experience Hospital admission Hospitalized hospitalized patient Impact intensive care liver liver functional tests Liver injury mechanical ventilation Mortality multivariate Cox regression obesity occurred outcome Patient patients patients hospitalized patients with COVID-19 predictor Prevalence Regional remained risk severe disease severity of COVID-19 Sex Test ULN with COVID-19
[DOI] 10.3390/jcm10184222 PMC 바로가기 [Article Type] Article

Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease

COVID-19 질병의 결과를 예측하기 위한 바이오마커로서의 폐혈량 분포 변경

Article

Published on 2021-09-162022-09-11
Journal: The European Respiratory Journal [Category] Fulltext, SARS, 바이오마커,

[키워드] adverse outcome adverse outcomes age Altered an area Biomarker Blood blood volume Care characteristic Chest computed tomography chest CT scan Chest CT scans Clinical outcome clinical outcomes Composite Computed tomography COVID-19 disease COVID-19 patient COVID-19 patients cross-sectional area distribution driver hospital hypothesised intubation Medical care Mortality multivariate model outcome Patient patients with COVID-19 patients without COVID-19 performed predict Predictive receiver receiver operating characteristic Retrospective analysis seeking significant decrease threshold thrombosis vascular inflammation vessel vessels Volume
[DOI] 10.1183/13993003.04133-2020 PMC 바로가기 [Article Type] Article